Differences in referral and use of complementary and alternative medicine between pediatric providers and patients

Brooke N Jenkins1, Nicole Vincent2, Michelle A Fortier3

  • 1University of California Irvine, Department of Psychology and Social Behavior, United States.

Insights

Pediatric health care providers referred more complementary and alternative medicine (CAM) therapies than parents reported using for their children. This suggests potential underutilization of CAM by pediatric patients.

Area of Science:

  • Pediatric Health
  • Complementary and Alternative Medicine (CAM)
  • Healthcare Provider Referrals

Background:

  • Complementary and Alternative Medicine (CAM) is increasingly utilized by pediatric populations.
  • Understanding the patterns of CAM use and healthcare provider (HCP) referral is crucial for integrated pediatric care.
  • Predictors of CAM use and referral in pediatric settings require further investigation.

Purpose of the Study:

  • To compare pediatric complementary and alternative medicine (CAM) use by caregivers with CAM referrals by pediatric health care providers (HCP).
  • To identify predictors associated with pediatric CAM use and HCP CAM referral.

Main Methods:

  • A survey study involving 283 parents/caregivers and 200 pediatric health care providers (HCP) at a children's hospital.
  • Participants indicated the use or consideration of 32 CAM interventions for pediatric patients.
  • Outcome measures included the number and types of CAM therapies endorsed.

Main Results:

  • HCPs referred the majority of CAM therapies significantly more often than caregivers reported their children used them.
  • Children from higher-income families, with older and more educated parents, who were White, and whose primary language was English were more likely to use CAM.
  • HCP CAM referral was not significantly predicted by years of practice or health care profession.

Conclusions:

  • HCPs referred CAM therapies more frequently than parents reported using them for their children.
  • Findings suggest potential underutilization of CAM therapies among pediatric patients.
  • Further research is needed to explore barriers to CAM use in pediatric populations.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
868
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
821
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
352
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
497
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
388
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
2.5K